Purification, reconstitution, and inhibition of cytochrome P-450 sterol Δ22-desaturase from the pathogenic fungus Candida glabrata

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 7, 1999, Pages 1725-1728

  Lamb, David C ^a   Maspahy, Segula ^a   Kelly, Diane E ^a   Manning, Nigel J ^b   Geber, Antonia ^c   Bennett, John E ^c   Kelly, Steven L ^a  

^a ABERYSTWYTH UNIVERSITY   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ERGOSTA 5,7 DIENOL; ERGOSTEROL; FLUCONAZOLE; FUNGAL PROTEIN; HEME; ITRACONAZOLE; KETOCONAZOLE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; STEROL 14ALPHA DEMETHYLASE; STEROL DELTA22 DESATURASE; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; DRUG BINDING; DRUG TARGETING; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME PURIFICATION; ENZYME RECONSTITUTION; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE;

EID: 0032814526     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.7.1725     Document Type: Article

References (23)

1. Gerber, A., C. A. Hitchcock, J. E. Swartz, F. S. Pullen, K. E. Marsden, K. J. Kwon-Chung, and J. E. Bennett. 1995. Deletion of the Candida glabrata ERG3 and ERC11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob. Agents Chemother. 39: 2708-2717.
2. Hata, S., T. Nishino, H. Katsuki, Y. Aoyama, and Y. Yoshida. 1983. Two species of cytochrome P450 involved in ergosterol biosynthesis of yeast. Biochem. Biophys. Res. Commun. 116:162-166.
3. 22-desaturation in ergosterol biosynthesis of yeast. Biochem. Biophys. Res. Commun. 103:272-277.
4. Hollomon, D. W. Personal communication.
5. 22-desaturase, and inhibition by azole antifungal agents. J. Biol. Chem. 272:9986-9988.
6. Kelly, S. L., D. C. Lamb, B. C. Baldwin, and D. E. Kelly. 1993. Benzo-(a)pyrene hydroxylase activity in yeast is mediated by P450 other than sterol 14α-demethylase. Biochem. Biophys. Res. Commun. 197:428-432.
7. Kelly, S. L., D. C. Lamb, A. J. Corran, B. C. Baldwin, and D. E. Kelly. 1995. Mode of action and resistance to azole antifungals associated with the formation of 14α-methylergosta-8,24(28)-dien-3β,6β-diol. Biochem. Biophys. Res. Commun. 207:910-915.
8. 22-desaturase. FEBS Lett. 377:217-220.
9. Kelly, S. L., D. C. Lamb, and D. E. Kelly. 1997. Sterol 22-desaturase, cytochrome P45061, possesses activity in xenobiotic metabolism. FEBS Lett. 412:233-235.
10. Kerridge, D., M. Fasoli, and F. J. Wayman. 1988. Drug resistance in Candida albicans and Candida glabrata. Ann. N.Y. Acad. Sci. 544:245-259.
11. Kerridge, D., and R. O. Nicholas. 1986. Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata. J. Antimicrob. Chemother. 18:39-49.
12. Lamb, D. C., D. E. Kelly, W. H. Schunck, A. Z. Shyadehi, M. Akhtar, D. J. Lowe, B. C. Baldwin, and S. L. Kelly. 1997. The mutation T315A in Candida albicans sterol 14α-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity. J. Biol. Chem. 272:5682-5688.
13. Musial, C. E., F. R. Cockerill III, and G. D. Roberts. 1988. Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin. Microbiol. Rev. 1:349-364.
14. Nicholas, R. O., J. A. Burton, D. Kerridge, and F. J. Wayman. 1987. Isolation of mutants of Candida glabrata resistant to miconazole. Crit. Rev. Microbiol. 15:103-110.
15. Omura, T., and R. Sato. 1964. The carbon monoxide binding pigment of liver microsomes. 1. Evidence for its haemoprotein nature. J. Biol. Chem. 239: 2370-2378.
16. Parks, L. W., C. D. K. Bottema, R. J. Rodriguez, and T. A. Lewis. 1985. Yeast sterols - yeast mutants as tools for the study of sterol metabolism. Methods Enzymol. 111:333-346.
17. Skaggs, B. A., J. F. Alexander, C. A. Pierson, K. S. Schweitzer, K. T. Chun, C. Koegel, R. Barbuch, and M. Bard. 1996. Cloning and characterization of the Saccharomyces cerevisiae C-22 sterol desaturase gene, encoding a second cytochrome P-450 involved in ergosterol biosynthesis. Gene 169:105-109.
18. Vanden Bossche, H., G. Willemsens, W. Cools, P. Marichal, and W. Lauwers. 1983. Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles. Biochem. Soc. Trans. 11:665-667.
19. Venkateswarlu, K., D. C. Lamb, D. E. Kelly, N. J. Manning, and S. L. Kelly. 1998. The N-terminal membrane domain of yeast NADPH-cytochrome P450 (CYP) oxidoreductase is not required for catalytic activity in sterol biosynthesis or in reconstitution of CYP activity. J. Biol. Chem. 273:4492-4496.
20. Vermillion, J. L., and M. J. Coon. 1978. Purified liver microsomal NADPH-cytochrome P-450 reductase. Spectral characterization of oxidation-reduction states. J. Biol. Chem. 253:2694-2704.
21. Warnock, D. W., J. Burke, N. J. Cope, E. M. Johnson, N. A. Von Fraunhofer, and E. W. Williams. 1988. Fluconazole resistance in Candida glabrata. Lancet ii:1310.
22. Watson, P. F., M. E. Rose, D. J. King, S. W. Ellis, H. England, and S. L. Kelly. 1989. Defective sterol C5-6 desaturation and azole resistance: a new hypothesis on the mode of action of azole antifungals. Biochem. Biophys. Res. Commun. 154:1170-1175.
23. Yoshida, Y., and Y. Aoyama. 1987. Interaction of azole antifungal agents with cytochrome P45014DM purified from Saccharomyces cerevisiae microsomes. Biochem. Pharmacol. 36:229-235.